Mike Evers, Author at ORTHOWORLD

Top 10 Takeaways from Orthopedics in 2019

As we prepared our 2019 revenue projections for public companies, we took note of the major drivers in orthopedics of late. It was a busy year, with some surprising developments. After considering the stories behind companies’ 2019 performance, we offer these 10 takeaways, with specific examples.

Nov 22, 2019

Medtronic’s Surgical Synergy Strategy Accelerates Growth in Spine

Company Revenue The Numbers

Medtronic’s spine sales grew above market in FY 2Q20 on the strength of their Surgical Synergy strategy, combining capital equipment and implant hardware.

Nov 20, 2019

aap Gains Funding to Support Antibacterial Silver Coating Technology

Investments The Numbers

aap Implantate received a funding commitment of up to €0.7 million (~USD $0.8 million) to conceive and qualify a human clinical study to support market approval of its antibacterial silver coating technology.

Nov 19, 2019

Wright Medical Growth Downturn Continued in Lead Up to Stryker Deal

Company Revenue The Numbers

Before its acquisition by Stryker, Wright continued to face challenges in Cartiva distribution and increased competition in the foot and ankle market.

Nov 14, 2019

SI-BONE Continues Growth with Reimbursement Wins

Company Revenue The Numbers

Continuing reimbursement wins and an expanding sales force drove SI-Bone’s 3Q19 revenue growth.

Nov 14, 2019

aap Sales Decline on U.S. Distribution Loss

Company Revenue The Numbers

aap Implantate's revenue decline in 3Q19 was attributed to the termination of a distributor sales relationship in the U.S.

Nov 14, 2019

Medicrea Growth Driven by U.S. Sales of Patient-Specific Implants

Company Revenue The Numbers

Medicrea's 3Q19 growth was due to growth in key markets like the U.S. and Belgium, in addition to continuing uptake of their patient-specific rods.

Nov 14, 2019

OrthoPediatrics Records Highest Revenue Quarter in Company History

Company Revenue The Numbers

OrthoPediatrics recorded its highest ever revenue for a quarter in 3Q19 on the strength of new product introductions and an expanded sales force.

Nov 11, 2019

Xtant Taps New CEO to Lead Turnaround Effort

Company Updates Competitive Landscape

Xtant Medical’s revenue continued to decline in 3Q19 as the company selected Sean Browne as the new President and CEO to lead a turnaround.

Nov 11, 2019

DJO Joint Replacement Growth Driven by New Products

Company Revenue The Numbers

DJO’s joint replacement business grew in the high single digits, a trend leadership expects to be able to sustain on a consistent basis.

Nov 11, 2019

Get the ORTHOWORLD Newsletter!

Contact Us